Short communication · 30 Apr 2026
Conference abstractPublished 29 Aug 2017
Adolescent premalignant cervical disease and delayed HPV vaccination
University of Mississippi, USA; Mississippi State Department of Health, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Human papillomavirus (HPV) causes 100% of cervical cancer and vaccination can prevent it. Immunization is grossly underutilized. Cervical cancer screening guidelines have changed and Pap smears are not recommended for females under 21 yearsold. Therefore, adolescents have potentially fewer wellness visits and missed opportunity for immunization and cancer prevention. Objective: The purpose of this study was to describe women below 21 years old who were diagnosed with premalignant cervical neoplasia and correlate the types and frequency of vaccinations received before abnormal Pap smear results. Method: A retrospective analysis of girls aged 14-20 years with high-grade Pap smears and cervical biopsy at State Health Departments in Mississippi, USA, between 2011 and 2014 were assessed for a history of vaccination. Descriptive statistics and a Chi-square analysis were conducted. Results: 15,201 females aged 14-20 years received pap smears from 2011-2014. Of those, 179 (1%) of females had high-grade pap smears; only 1 had immunization at age 12. Biopsy confirmed 62% had high-grade dysplasia. Only 51 (28.5%) had documentation of one HPV shot at a mean age of 16. Only 1 of these 51 who were vaccinated received the dose at the recommended age of 9-12 ((ÏÂ?2=48.000, df=3, p=0.001). Black females were significantly more likely to receive an HPV vaccine than whites ((ÏÂ?2=12.166, df=2, p=0.002). Discussion: Cervical cancer mortality is highest in Mississippi with the lowest rates of HPV vaccination. The American College of Obstetrics and Gynecology reports a lack of sufficient screening data in this age group contributed to changes in guidelines. The Center for Disease Control suggests further investigation of race and lack of vaccination to refine screening guidelines. Providing strong recommendations for vaccination at age 9-12 may decrease cervical cancer.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Gynecology & Obstetrics.
Conference abstract · 19 Nov 2025
Loss of lncRNAs 1700101O22Rik and 1700027A15Rik causes sperm malformation and subfertility
Conference abstract · 19 Nov 2025
Linking Mitochondrial Fatty Acid Metabolism to Follicular Health: A Novel Perspective on Premature Ovarian Insufficiency
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalGynecology & Obstetrics
- SubjectReproductive Medicine & Gynaecology
- BylineArticles whose byline prints “Carolann Risley”
- BylineArticles whose byline prints “Kim Geisinger”
- BylineArticles whose byline prints “Lei Zhang”
